74%
of retail investor accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
74%
of retail investor accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
ConvaTec Group PLC
Closed
SectorFinance
220.6 -2.48
Overview
Share price change
24h
Min
219.8
Max
221.4
Income | -34M 71M |
|---|---|
Sales | 85M 1.3B |
P/E Sector Avg | 39.367 39.62 |
EPS | 0.08 |
Dividend yield | 3.04 |
Profit margin | 5.575 |
Employees | 10,910 |
EBITDA | 57M 338M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +41.17% upside |
Dividend yield Sector Avg | 3.04% 4.52% |
|---|
Market Cap | -253M 4.6B |
|---|---|
Previous open | 223.08 |
Previous close | 220.6 |
News Sentiment
By Acuity
13%
87%
21 / 439 Finance
ConvaTec Group PLC Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
ConvaTec Group PLC Forecast
Price Target
By TipRanks
41.17% upside
12 Months Forecast
Average 311.7 GBX 41.17%
High 340 GBX
Low 270 GBX
Based on 11 Wall Street analysts offering 12 month price targets forConvaTec Group PLC - Dist in the last 3 months.
Sentiment
By Acuity
21 / 439 Finance
News Sentiment
Very Strong Bullish Evidence
Volatility
Below average
News Volume (RCV)
Above average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About ConvaTec Group PLC
ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer. In addition, the company offers continence care products and services for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other causes, as well as critical care devices and products used in intensive care units and hospital settings. Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for pumps used in continuous subcutaneous infusion treatments for conditions such as parkinson's disease. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. ConvaTec Group PLC was founded in 1978 and is headquartered in London, the United Kingdom.
Other stocks from the sector
Live chat